Denosumab Therapy for Giant Cell Tumor of Bone Pulmonary Metastasis
- PMID: 28573059
- PMCID: PMC5442345
- DOI: 10.1155/2017/2302597
Denosumab Therapy for Giant Cell Tumor of Bone Pulmonary Metastasis
Abstract
Case: A 68-year-old female was diagnosed with giant cell tumor of bone (GCTB) metastatic to her lungs. The patient was treated with IV denosumab for the course of 4.5 years for these metastases. The metastatic tumor burden decreased significantly after only 3 months of therapy. The size of the metastases has been stable for over 4 years.
Conclusion: Denosumab therapy has promise in the treatment of GCTB, including pulmonary metastasis. However, the long-term role of denosumab for pulmonary metastases is yet to be determined.
References
-
- Cooper A., Travers B. Surgical Essays: Part I. 2nd. London, UK: Cox and Son; 1818.
-
- Jaffe H. L., Portis R. B. Giant cell tumor of bone. Its pathologic appearance, grading. Arch Pathology. 1940;30993
-
- Coley B. L. Giant Cell Tumor (Osteoclastoma) New York, NY, USA: Hoeber; 1960. (Neoplasms of Bone and Related Conditions).
Publication types
LinkOut - more resources
Full Text Sources
Other Literature Sources
